Table 1.
Year | Age (Years) | Gender | Day of diagnosisa | Site of the thrombus | Treatmentb | Time for resolutionc | Ejection Fraction % | Thrombo Embolismd | Reference |
---|---|---|---|---|---|---|---|---|---|
2003 | 74 | F | 4 | 4 × 4 mm, LV apex | Warfarin | 2w | Right hemiparesis | [6] | |
2003 | 64 | F | 2 | LV | Anticoagulation | 12w | 40 | [7] | |
2004 | 76 | F | 6 | Heparin and warfarin | 2w | [35] | |||
2004 | 57 | F | 2 | LV apex, 2.0 × 1.5 cm | Heparin and warfarin | 4w | Right upper limb hemiplegia | [36] | |
2004 | 44 | F | 11 weeks | LV apex | Urokinase, warfarin | Renal infarct | [17] | ||
2006 | 64 | F | LV apex, 13 × 8 mm | Anticoagulant | 4w | [37] | |||
2006 | 76 | F | LV apex | Anticoagulant | 3w | 35 | [38] | ||
2007 | 54 | F | 2 | LV apex | Heparin and warfarin | 1w | [15] | ||
2007 | 74 | F | 3 | LV apex | Heparin and warfarin | 12d | 33 | [39] | |
2007 | 70 | F | 3 | LV apex | Anticoagulant | 3 m | Sensory aphasia | [40] | |
2007 | 74 | M | 14 | 20 × 15 mm LV apex |
Anticoagulant | 7w | 30 | [10] | |
2007 | 74 | F | LV apex | Anticoagulant | 2 m | 40 | [41] | ||
2008 | 69 | F | 1 | LV apex, Two mobile thrombi 5 × 6 mm and 8 × 10 mm | Heparin and phenprocoumon | 4w | 39 | [8] | |
2008 | 69 | F | 8 | Mobile thrombus adjacent to the posteromedial papillary muscle | Heparin | 9d | 30 | [8] | |
2008 | 43 | F | 4 | LV apex | Heparin | 11d | 34 | [8] | |
2008 | 69 | F | 3 | 28 × 22 mm anterior and anteroseptal wall, 4 × 4 mm mobile thrombus adjacent to the anterolateral papillary muscle | Heparin | 27d | 45 | [8] | |
2008 | 55 | F | 2 | LV apex | Heparin and warfarin | 1 m | [19] | ||
2008 | 53 | F | LV apex | Heparin aspirin | 2w | 32 | [42] | ||
2008 | 74 | F | Multiple thrombotic masses | Warfarin | 2w | 35 | Dysphasia, right arm paresis | [26] | |
2008 | 43 | F | 5 | LV apex | Heparin and warfarin | 8d | <25 | Right renal infarct | [43] |
2008 | 64 | F | LV apex | Warfarin | 45 | Broca’s aphasia | [44] | ||
2009 | 28 | F | 3 | LV apex | Heparin and warfarin | 3w | 25 | [20] | |
2009 | 57 | M | LV apex | Heparin and warfarin | 2w | 48 | [45] | ||
2011 | 78 87 71 82 55 |
F F F F F |
Mural in 2 cases and protruding in 3 cases | Anticoagulant | 4w | 45 ± 6% | Cerebral infarction in one patient | [4] | |
2011 | 62 | F | 35 | LV apex | Heparin and warfarin | 3 m | 18 | [16] | |
2011 | 76 | F | 8 | LV apex, 24 × 25 mm | Heparin and warfarin | 1w | 18 | Multiple brain embolic infarctions | [46] |
2011 | 68 | F | 3 | LV apex, 26 × 29 mm | Heparin and warfarin | 12d | [47] | ||
2011 | 69 | F | 6 | LV apex | Anticoagulant | 14d | [48] | ||
2012 | 78 | F | LV apex | Anticoagulant | 2w | 50 | [49] | ||
2012 | 70 | F | 13 | LV apex | Anticoagulant | 55 | [50] | ||
2012 | 29 | F | 2 | Mid right ventricular cavity, 16 × 9 8 mm, | Anticoagulant | 7d | [22] | ||
2012 | 48 | M | 15 | Apical inferior wall, 28 × 16 mm | Sx | [25] | |||
2012 | 78 | F | 7 | LV apex | Heparin | 17d | [30] | ||
2013 | 52 | F | 3 | LV apex, 37 × 21 mm | Heparin and warfarin | Multifocal micro infarctions in the brain, pleen and kidneys | [27] | ||
2013 | 78 | F | Attached to septoapical wall, 30 × 15 mm | Aspirin, heparin | 35 | Left hemiparesis and dysarthria, large thrombus at the trunk and branches of the superior mesenteric artery | [24] | ||
2013 | 50 | M | LV apex, 3.6 cm × 1.7 cm | Enoxaparin, Clopidogrel and warfarin | 7w | 45 | Dense left sided hemiplegia, left homonymous hemianopia, aphasia | [31] | |
2013 | 63 | F | 3 weeks | LV apex, 1.10 × 2.12 cm | Heparin and warfarin | 3 m | 43 | [18] | |
2013 | 58 | F | 2 | Heparin, warfarin and sx | [33] | ||||
2015 | 66 | F | LV apex | Heparin, acetyl-salicylic acid and clopidogrel | 17d | Ischemic infarctions of the left median cerebral artery | [51] | ||
2015 | 59 | F | 13 | LV apex | Heparin, Warfarin, sx | <25 | [21] | ||
2016 | 48 | F | LV apex | Anticoagulant | 3 m | Right femoral artery embolism | [52] | ||
2016 | 57 | F | 4 | LV apex, 2.3 × 3.3 cm | Warfarin | 15d | 35 | [53] | |
2016 | 61 | F | LV apex | Heparin and warfarin | 35 | [14] | |||
2016 | 55 | F | LV apex, 20 × 10 mm | Warfarin | 3 m | [54] | |||
2017 | 48 | F | LV apex | Heparin and warfarin | 30 | [55] | |||
2017 | 88 | F | Biventricular | Heparin | 35 | [21] | |||
2003 | 74 | F | 4 | 4 × 4 mm, LV apex | Warfarin | 2w | Right hemiparesis | [6] | |
2003 | 64 | F | 2 | LV | Anticoagulation | 12w | 40 | [7] | |
2004 | 76 | F | 6 | Heparin and warfarin | 2w | [35] | |||
2004 | 57 | F | 2 | LV apex, 2.0 × 1.5 cm | Heparin and warfarin | 4w | Right upper limb hemiplegia | [36] | |
2004 | 44 | F | 11 weeks | LV apex | Urokinase, warfarin | Renal infarct | [17] | ||
2006 | 64 | F | LV apex, 13 × 8 mm | Anticoagulant | 4w | [37] | |||
2006 | 76 | F | LV apex | Anticoagulant | 3w | 35 | [38] | ||
2007 | 54 | F | 2 | LV apex | Heparin and warfarin | 1w | [15] | ||
2007 | 74 | F | 3 | LV apex | Heparin and warfarin | 12d | 33 | [39] | |
2007 | 70 | F | 3 | LV apex | Anticoagulant | 3 m | Sensory aphasia | [40] | |
2007 | 74 | M | 14 | 20 × 15 mm LV apex |
Anticoagulant | 7w | 30 | [10] | |
2007 | 74 | F | LV apex | Anticoagulant | 2 m | 40 | [41] | ||
2008 | 69 | F | 1 | LV apex, Two mobile thrombi 5 × 6 mm and 8 × 10 mm | Heparin and phenprocoumon | 4w | 39 | [8] | |
2008 | 69 | F | 8 | Mobile thrombus adjacent to the posteromedial papillary muscle | Heparin | 9d | 30 | [8] | |
2008 | 43 | F | 4 | LV apex | Heparin | 11d | 34 | [8] | |
2008 | 69 | F | 3 | 28 × 22 mm anterior and anteroseptal wall, 4 × 4 mm mobile thrombus adjacent to the anterolateral papillary muscle | Heparin | 27d | 45 | [8] | |
2008 | 55 | F | 2 | LV apex | Heparin and warfarin | 1 m | [19] | ||
2008 | 53 | F | LV apex | Heparin aspirin | 2w | 32 | [42] | ||
2008 | 74 | F | Multiple thrombotic masses | Warfarin | 2w | 35 | Dysphasia, right arm paresis | [26] | |
2008 | 43 | F | 5 | LV apex | Heparin and warfarin | 8d | <25 | Right renal infarct | [43] |
2008 | 64 | F | LV apex | Warfarin | 45 | Broca’s aphasia | [44] | ||
2009 | 28 | F | 3 | LV apex | Heparin and warfarin | 3w | 25 | [20] | |
2009 | 57 | M | LV apex | Heparin and warfarin | 2w | 48 | [45] | ||
2011 | 78 87 71 82 55 |
F F F F F |
Mural in 2 cases and protruding in 3 cases | Anticoagulant | 4w | 45 ± 6% | Cerebral infarction in one patient | [4] | |
2011 | 62 | F | 35 | LV apex | Heparin and warfarin | 3 m | 18 | [16] | |
2011 | 76 | F | 8 | LV apex, 24 × 25 mm | Heparin and warfarin | 1w | 18 | Multiple brain embolic infarctions | [46] |
2011 | 68 | F | 3 | LV apex, 26 × 29 mm | Heparin and warfarin | 12d | [47] | ||
2011 | 69 | F | 6 | LV apex | Anticoagulant | 14d | [48] | ||
2012 | 78 | F | LV apex | Anticoagulant | 2w | 50 | [49] | ||
2012 | 70 | F | 13 | LV apex | Anticoagulant | 55 | [50] | ||
2012 | 29 | F | 2 | Mid right ventricular cavity, 16 × 9 8 mm, | Anticoagulant | 7d | [22] | ||
2012 | 48 | M | 15 | Apical inferior wall, 28 × 16 mm | Sx | [25] | |||
2012 | 78 | F | 7 | LV apex | Heparin | 17d | [30] | ||
2013 | 52 | F | 3 | LV apex, 37 × 21 mm | Heparin and warfarin | Multifocal micro infarctions in the brain, spleen and kidneys | [27] | ||
2013 | 78 | F | Attached to septoapical wall, 30 × 15 mm | Aspirin, heparin | 35 | Left hemiparesis and dysarthria, large thrombus at the trunk and branches of the superior mesenteric artery | [24] | ||
2013 | 50 | M | LV apex, 3.6 cm × 1.7 cm | Enoxaparin, Clopidogrel and warfarin | 7w | 45 | Dense left sided hemiplegia, left homonymous hemianopia, aphasia | [31] | |
2013 | 63 | F | 3 weeks | LV apex, 1.10 × 2.12 cm | Heparin and warfarin | 3 m | 43 | [18] | |
2013 | 58 | F | 2 | Heparin, warfarin and sx | [33] | ||||
2015 | 66 | F | LV apex | Heparin, acetyl-salicylic acid and clopidogrel | 17d | Ischemic infarctions of the left median cerebral artery | [51] | ||
2015 | 59 | F | 13 | LV apex | Heparin, Warfarin, sx | <25 | [21] | ||
2016 | 48 | F | LV apex | Anticoagulant | 3 m | Right femoral artery embolism | [52] | ||
2016 | 57 | F | 4 | LV apex, 2.3 × 3.3 cm | Warfarin | 15d | 35 | [53] | |
2016 | 61 | F | LV apex | Heparin and warfarin | 35 | [14] | |||
2016 | 55 | F | LV apex, 20 × 10 mm | Warfarin | 3 m | [54] | |||
2017 | 48 | F | LV apex | Heparin and warfarin | 30 | [55] | |||
2017 | 88 | F | Biventricular | Heparin | 35 | [21] | |||
2003 | 74 | F | 4 | 4 × 4 mm, LV apex | Warfarin | 2w | Right hemiparesis | [6] | |
2003 | 64 | F | 2 | LV | Anticoagulation | 12w | 40 | [7] | |
2004 | 76 | F | 6 | Heparin and warfarin | 2w | [34] | |||
2004 | 57 | F | 2 | LV apex, 2.0 × 1.5 cm | Heparin and warfarin | 4w | Right upper limb hemiplegia | [35] | |
2004 | 44 | F | 11 weeks | LV apex | Urokinase, warfarin | Renal infarct | [17] | ||
2006 | 64 | F | LV apex, 13 × 8 mm | Anticoagulant | 4w | [36] | |||
2006 | 76 | F | LV apex | Anticoagulant | 3w | 35 | [37] | ||
2007 | 54 | F | 2 | LV apex | Heparin and warfarin | 1w | [15] | ||
2007 | 74 | F | 3 | LV apex | Heparin and warfarin | 12d | 33 | [38] | |
2007 | 70 | F | 3 | LV apex | Anticoagulant | 3 m | Sensory aphasia | [39] | |
2007 | 74 | M | 14 | 20 × 15 mm LV apex |
Anticoagulant | 7w | 30 | [10] | |
2007 | 74 | F | LV apex | Anticoagulant | 2 m | 40 | [40] | ||
2008 | 69 | F | 1 | LV apex, Two mobile thrombi 5 × 6 mm and 8 × 10 mm | Heparin and phenprocoumon | 4w | 39 | [8] | |
2008 | 69 | F | 8 | Mobile thrombus adjacent to the posteromedial papillary muscle | Heparin | 9d | 30 | [8] | |
2008 | 43 | F | 4 | LV apex | Heparin | 11d | 34 | [8] | |
2008 | 69 | F | 3 | 28 × 22 mm anterior and anteroseptal wall, 4 × 4 mm mobile thrombus adjacent to the anterolateral papillary muscle | Heparin | 27d | 45 | [8] | |
2008 | 55 | F | 2 | LV apex | Heparin and warfarin | 1 m | [19] | ||
2008 | 53 | F | LV apex | Heparin aspirin | 2w | 32 | [41] | ||
2008 | 74 | F | Multiple thrombotic masses | Warfarin | 2w | 35 | Dysphasia, right arm paresis | [24] | |
2008 | 43 | F | 5 | LV apex | Heparin and warfarin | 8d | <25 | Right renal infarct | [42] |
2008 | 64 | F | LV apex | Warfarin | 45 | Broca’s aphasia | [43] | ||
2009 | 28 | F | 3 | LV apex | Heparin and warfarin | 3w | 25 | [44] | |
2009 | 57 | M | LV apex | Heparin and warfarin | 2w | 48 | [45] | ||
2011 | 78 87 71 82 55 |
F F F F F |
Mural in 2 cases and protruding in 3 cases | Anticoagulant | 4w | 45 ± 6% | Cerebral infarction in one patient | [4] | |
2011 | 62 | F | 35 | LV apex | Heparin and warfarin | 3 m | 18 | [16] | |
2011 | 76 | F | 8 | LV apex, 24 × 25 mm | Heparin and warfarin | 1w | 18 | Multiple brain embolic infarctions | [46] |
2011 | 68 | F | 3 | LV apex, 26 × 29 mm | Heparin and warfarin | 12d | [47] | ||
2011 | 69 | F | 6 | LV apex | Anticoagulant | 14d | [48] | ||
2012 | 78 | F | LV apex | Anticoagulant | 2w | 50 | [49] | ||
2012 | 70 | F | 13 | LV apex | Anticoagulant | 55 | [50] | ||
2012 | 29 | F | 2 | Mid right ventricular cavity, 16 × 9 8 mm, | Anticoagulant | 7d | [20] | ||
2012 | 48 | M | 15 | Apical inferior wall, 28 × 16 mm | Sx | [23] | |||
2012 | 78 | F | 7 | LV apex | Heparin | 17d | [28] | ||
2013 | 52 | F | 3 | LV apex, 37 × 21 mm | Heparin and warfarin | Multifocal micro infarctions in the brain, spleen and kidneys | [25] | ||
2013 | 78 | F | Attached to septoapical wall, 30 × 15 mm | Aspirin, heparin | 35 | Left hemiparesis and dysarthria, large thrombus at the trunk and branches of the superior mesenteric artery | [22] | ||
2013 | 50 | M | LV apex, 3.6 cm × 1.7 cm | Enoxaparin, Clopidogrel and warfarin | 7w | 45 | Dense left sided hemiplegia, left homonymous hemianopia, aphasia | [29] | |
2013 | 63 | F | 3 weeks | LV apex, 1.10 × 2.12 cm | Heparin and warfarin | 3 m | 43 | [18] | |
2013 | 58 | F | 2 | Heparin, warfarin and sx |
[31] | ||||
2015 | 66 | F | LV apex | Heparin, acetyl-salicylic acid and clopidogrel | 17d | Ischemic infarctions of the left median cerebral artery | [51] | ||
2015 | 59 | F | 13 | LV apex | Heparin, Warfarin, sx | <25 | [32] | ||
2016 | 48 | F | LV apex | Anticoagulant | 3 m | Right femoral artery embolism | [52] | ||
2016 | 57 | F | 4 | LV apex, 2.3 × 3.3 cm | Warfarin | 15d | 35 | [53] | |
2016 | 61 | F | LV apex | Heparin and warfarin | 35 | [14] | |||
2016 | 55 | F | LV apex, 20 × 10 mm | Warfarin | 3 m | [54] | |||
2017 | 48 | F | LV apex | Heparin and warfarin | 30 | [55] | |||
2017 | 88 | F | Biventricular | Heparin | 35 | [21] |
F female, M male,
Day of diagnosisa = the date of diagnosis from the onset of symptoms / diagnosis of takotsubo cardiomyopathy, given in number of days, in 2 cases given in weeks
Treatmentb = anticoagulant = In case reports which has not specified the anticoagulant used, Sx = ventriculotomy and surgical thrombectomy
Time for resolutionc = d days, w weeks, m months
Thrombo Embolismd = Thrombo embolic episodes diagnosed after the detection of ventricular thrombus